Relative bioavailability trial to investigate the pharmacokinetics of tapentadol following the administration of 3 prototype tapentadol 25 mg prolonged release (PR) granule formulations compared to a Palexia PR 25 mg tablet in healthy adult subjects.
Phase of Trial: Phase I
Latest Information Update: 07 Jul 2015
At a glance
- Drugs Tapentadol (Primary) ; Tapentadol
- Indications Pain
- Focus Pharmacokinetics
- Sponsors Grunenthal
- 04 Jul 2015 Status changed from recruiting to completed, according to European Clinical Trials Database record.
- 19 Nov 2014 New trial record